Literature DB >> 6999025

Quantification of arabinitol in serum by selected ion monitoring as a diagnostic technique in invasive candidiasis.

J Roboz, R Suzuki, J F Holland.   

Abstract

D-Arabinitol was identified by mass spectrometry as a metabolite of Candida albicans and Candida tropicalis. For quantification, serum was deproteinized with acetone, the supernatant was evaporated to dryness, the silyl derivative was formed, and a portion was injected into a combined gas chromatograph-mass spectrometer system. Erythritol or 2-deoxy-galactitol was the internal standard. The protonated molecular ions, obtained in chemical ionization with isobutane, were monitored. For 39 normal subjects the mean endogenous arabinitol concentration was 0.52 microgram/ml (standard deviation, +/- 0.34). An increment of 0.2 microgram of arabinitol per ml could be quantified. Of 11 cases with diagnosed invasive candidiasis, 9 had arabinitol levels > 1.2 microgram/ml (8 microM) in the range of 1.2 to 25.0 micrograms/ml; the remaining 2 cases had levels in the normal range. Six cases of diagnosed colonized candidiasis showed normal arabinitol levels.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6999025      PMCID: PMC273644          DOI: 10.1128/jcm.12.4.594-601.1980

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases.

Authors:  C Singer; M H Kaplan; D Armstrong
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

2.  Hospital-acquired fungemia. Its natural course and clinical significance.

Authors:  J J Klein; C Watanakunakorn
Journal:  Am J Med       Date:  1979-07       Impact factor: 4.965

Review 3.  Acute infections in cancer patients.

Authors:  S J Ketchel; V Rodriguez
Journal:  Semin Oncol       Date:  1978-06       Impact factor: 4.929

4.  The serum polyol pattern and the urinary polyol excretion in diabetic and in uremic patients.

Authors:  E Pitkänen
Journal:  Clin Chim Acta       Date:  1972-04       Impact factor: 3.786

Review 5.  The utilization of sugars by yeasts.

Authors:  J A Barnett
Journal:  Adv Carbohydr Chem Biochem       Date:  1976       Impact factor: 12.200

Review 6.  Hematologic malignancies and other marrow failure states: progress in the management of complicating infections.

Authors:  A S Levine; S C Schimpff; R G Graw; R C Young
Journal:  Semin Hematol       Date:  1974-04       Impact factor: 3.851

7.  Candidiasis: detection by gas-liquid chromatography of D-arabinitol, a fungal metabolite, in human serum.

Authors:  T E Kiehn; E M Bernard; J W Gold; D Armstrong
Journal:  Science       Date:  1979-11-02       Impact factor: 47.728

8.  Mannan antigenemia in the diagnosis of invasive Candida infections.

Authors:  M H Weiner; W J Yount
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

9.  Rapid identification of Candida albicans septicemia in man by gas-liquid chromatography.

Authors:  G G Miller; M W Witwer; A I Braude; C E Davis
Journal:  J Clin Invest       Date:  1974-11       Impact factor: 14.808

  9 in total
  26 in total

1.  A rapid, automated enzymatic fluorometric assay for determination of D-arabinitol in serum.

Authors:  S F Yeo; Y Zhang; D Schafer; S Campbell; B Wong
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  Production of the hexitol D-mannitol by Cryptococcus neoformans in vitro and in rabbits with experimental meningitis.

Authors:  B Wong; J R Perfect; S Beggs; K A Wright
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

3.  Effects of gastrointestinal candidiasis, antibiotics, dietary arabinitol, and cortisone acetate on levels of the Candida metabolite D-arabinitol in rat serum and urine.

Authors:  B Wong; K L Brauer; J R Clemens; S Beggs
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

4.  Comparison of enzyme immunoassay and gas-liquid chromatography for the rapid diagnosis of invasive candidiasis in cancer patients.

Authors:  L de Repentigny; L D Marr; J W Keller; A W Carter; R J Kuykendall; L Kaufman; E Reiss
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

5.  Comparison of serum mannan, arabinitol, and mannose in experimental disseminated candidiasis.

Authors:  L de Repentigny; R J Kuykendall; F W Chandler; J R Broderson; E Reiss
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

Review 6.  New developments in the diagnosis of opportunistic fungal infection.

Authors:  V Hopwood; D W Warnock
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

7.  D-arabitol metabolism in Candida albicans: studies of the biosynthetic pathway and the gene that encodes NAD-dependent D-arabitol dehydrogenase.

Authors:  B Wong; J S Murray; M Castellanos; K D Croen
Journal:  J Bacteriol       Date:  1993-10       Impact factor: 3.490

8.  Evaluation of serum arabinitol as a diagnostic test for candidiasis.

Authors:  C L Wells; M S Sirany; D J Blazevic
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

9.  Estimations of serum arabinitol for diagnosing invasive candidosis.

Authors:  A G Deacon
Journal:  J Clin Pathol       Date:  1986-08       Impact factor: 3.411

10.  Determination of serum arabinitol levels by mass spectrometry in patients with postoperative candidiasis.

Authors:  L Lehtonen; A Rantala; P Oksman; E Eerola; O P Lehtonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-05       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.